These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19923315)

  • 1. Novel combinations for treating metastatic breast cancer: improving the odds. Introduction.
    Schwartz J; Wong ST
    Am J Health Syst Pharm; 2009 Dec; 66(23 Suppl 6):S1-2. PubMed ID: 19923315
    [No Abstract]   [Full Text] [Related]  

  • 2. Current combination chemotherapy regimens for metastatic breast cancer.
    Schwartz J
    Am J Health Syst Pharm; 2009 Dec; 66(23 Suppl 6):S3-8. PubMed ID: 19923317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging treatment combinations: integrating therapy into clinical practice.
    Wong ST
    Am J Health Syst Pharm; 2009 Dec; 66(23 Suppl 6):S9-S14. PubMed ID: 19923318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
    Johnston SR
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutic approaches to the treatment of metastatic breast cancer.
    Fernández Y; Cueva J; Palomo AG; Ramos M; de Juan A; Calvo L; García-Mata J; García-Teijido P; Peláez I; García-Estévez L
    Cancer Treat Rev; 2010 Feb; 36(1):33-42. PubMed ID: 19883980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer (metastatic).
    Johnston S; Stebbing J
    Clin Evid; 2003 Dec; (10):1975-2002. PubMed ID: 15555190
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives.
    Gligorov J; Azria D; Namer M; Khayat D; Spano JP
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):115-28. PubMed ID: 17702596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modern principles of chemotherapy of metastatic breast cancer].
    Syvak LA; Maĭdanevych NM; Lial'kin SA; Askolskyĭ AV; Alpat'ieva SIu; Bagirian MA; Klimanov MIu; Kasap NV
    Lik Sprava; 2011; (1-2):70-5. PubMed ID: 21954638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer (metastatic).
    Stebbing J; Glassman R
    Clin Evid; 2004 Jun; (11):2266-99. PubMed ID: 15652111
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy and hormone therapy of metastatic breast cancer.
    Paterson AH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
    Pusztai L; Esteva FJ; Cristofanilli M; Hung MC; Hortobagyi GN
    Cancer Treat Rev; 1999 Oct; 25(5):271-7. PubMed ID: 10544071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we hitting the right combination for hormonally sensitive breast cancer?
    Tripathy D
    J Clin Oncol; 2009 Jun; 27(16):2580-2. PubMed ID: 19380439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
    Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin in Treating Breast Cancer: A Review.
    Wang Y; Yu J; Cui R; Lin J; Ding X
    J Lab Autom; 2016 Dec; 21(6):723-731. PubMed ID: 27325106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing chemotherapy-free survival for the ER/HER2-positive metastatic breast cancer patient.
    Glück S; Arteaga CL; Osborne CK
    Clin Cancer Res; 2011 Sep; 17(17):5559-61. PubMed ID: 21764887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer (metastatic).
    Stebbing J; Crane J; Gaya A
    Clin Evid; 2006 Jun; (15):2331-59. PubMed ID: 16973089
    [No Abstract]   [Full Text] [Related]  

  • 19. A biological approach to breast cancer.
    Wall P
    Radiography; 1986; 52(603):125-30. PubMed ID: 3749491
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of tumor stroma on drug response in breast cancer.
    Dittmer J; Leyh B
    Semin Cancer Biol; 2015 Apr; 31():3-15. PubMed ID: 24912116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.